SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-176
OR 15d-17 THEREUNDER
PHARMOS CORPORATION
---------------------------------------------
(EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER
2 INNOVATION DRIVE, ALACHUA, FL 32615
----------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
ISSUER'S TELEPHONE NUMBER, INCLUDING AREA CODE 904-462-1210
------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of Security Common Stock, par value $.03 per share
----------------------------------------
2. Number of shares outstanding before the change 23,130,679
------------
3. Number of shares outstanding after the change 29,130,679
-------------
4. Effective date of change September 14, 1995
---------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.): private
placement issuance
Give brief description of transaction: On September 14, 1995, the Company issued
-----------------------------------------
6,000,000 million shares of unregistered Common Stock in a private placement
- ----------------------------------------------------------------------------
transaction.
- -----------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change N/A
---------------------
2. Name after change N/A
---------------------
3. Effective date of charter amendment changing name N/A
---------
4. Date of shareholder approval of change, if required N/A
---------
Date: January 4, 1996
---------------
/s/ S. Colin Neill
-------------------------------
S. Colin Neill
Acting Chief Financial Officer
